Table: begin end state 1 5 non-cytoplasmic 6 25 transmembrane 26 31 cytoplasmic 32 52 transmembrane 53 63 non-cytoplasmic 64 83 transmembrane 84 103 cytoplasmic 104 133 transmembrane 134 138 non-cytoplasmic 139 161 transmembrane 162 180 cytoplasmic 181 201 transmembrane 202 230 non-cytoplasmic 231 254 transmembrane 255 264 cytoplasmic 265 287 transmembrane 288 308 non-cytoplasmic 309 322 transmembrane 323 346 non-cytoplasmic 347 382 transmembrane 383 388 cytoplasmic 389 412 transmembrane 413 423 non-cytoplasmic 424 446 transmembrane 447 449 cytoplasmic
Input: >AO356_07790 AO356_07790 permease DsdX MAPAFGYWLLVYAAIAIIALIVLIARYRLNPFIVITLVSIGLALLAGMPPSSVVGAYEAG VGKTLGHIALVVALGTMLGKMMAESGGAERMAQTLIERFGERNAHWAMVCIAFLVGLPLF FEVGFVLLVPIAFTIARRVGVSILMVGLPMVAGLSVVHALVPPHPAAMLAVQAFQASVGQ TLLYAILIGIPTAIIAGPLYAKFIVPRIQLPAENPLERQFLDREPRARLPGFGVTLGTIL LPVILMLIGGWANLISTPGSGFNQFLLFIGNSVIALLLATVLSFWTLGLAQGFNRESILK FTNECLAPTASITLLVGAGGGLNRILVDAGVTQQIVGLAQEFQLSPLVMGWLFAALMRVA TGSATVAMTTASGIVAPVAIGLGYPHPELLVLATGAGSVIFSHVNDGGFWLIKEYFNMTV TQTFKTWTVLETLISVVAFALTLGLSRLL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server